These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10482810)

  • 21. Influence of cyclooxygenase inhibitors on the central histaminergic stimulations of hypothalamic - pituitary - adrenal axis.
    Bugajski AJ; Thor P; Głód R; Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2003 Dec; 54(4):643-52. PubMed ID: 14726617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delta(9)-tetrahydrocannabinol enhances an increase of plasma corticosterone levels induced by forced swim-stress.
    Sano K; Koushi E; Irie K; Higuchi S; Tsuchihashi R; Kinjo J; Egashira N; Oishi R; Uchida N; Nagai H; Nishimura R; Tanaka H; Morimoto S; Mishima K; Iwasaki K; Fujiwara M
    Biol Pharm Bull; 2009 Dec; 32(12):2065-7. PubMed ID: 19952430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats.
    Nava F; Carta G; Gessa GL
    Pharmacol Biochem Behav; 2000 May; 66(1):183-7. PubMed ID: 10837859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
    Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
    Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
    Tanda G; Pontieri FE; Di Chiara G
    Science; 1997 Jun; 276(5321):2048-50. PubMed ID: 9197269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.
    Weidenfeld J; Feldman S; Mechoulam R
    Neuroendocrinology; 1994 Feb; 59(2):110-2. PubMed ID: 8127398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
    Lichtman AH; Martin BR
    Psychopharmacology (Berl); 1996 Jul; 126(2):125-31. PubMed ID: 8856831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
    Freedland CS; Whitlow CT; Miller MD; Porrino LJ
    Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.
    Maneuf YP; Nash JE; Crossman AR; Brotchie JM
    Eur J Pharmacol; 1996 Jul; 308(2):161-4. PubMed ID: 8840127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat.
    Saphier D; Welch JE; Chuluyan HE
    Eur J Pharmacol; 1993 May; 236(2):183-91. PubMed ID: 8391456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH; Fisher J; Martin BR
    Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    Eur J Pharmacol; 1995 Aug; 282(1-3):R1-2. PubMed ID: 7498260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.
    Pistis M; Ferraro L; Pira L; Flore G; Tanganelli S; Gessa GL; Devoto P
    Brain Res; 2002 Sep; 948(1-2):155-8. PubMed ID: 12383968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat.
    Yamauchi N; Shibasaki T; Wakabayashi I; Demura H
    Brain Res; 1997 Nov; 777(1-2):140-6. PubMed ID: 9449422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.